Cleared Traditional

C.C. Life 21 (K230459) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K230459 · 21 Equipment S.R.L. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2023
Decision
240d
Days
Class 2
Risk

K230459 is an FDA 510(k) clearance for the C.C. Life 21. Classified as Stimulator, Transcutaneous Electrical, Aesthetic Purposes (product code NFO), Class II - Special Controls.

Submitted by 21 Equipment S.R.L. (Torino, IT). The FDA issued a Cleared decision on October 19, 2023 after a review of 240 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all 21 Equipment S.R.L. devices

Submission Details

510(k) Number K230459 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 21, 2023
Decision Date October 19, 2023
Days to Decision 240 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
92d slower than avg
Panel avg: 148d · This submission: 240d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes

All 50
Devices cleared under the same product code (NFO) and FDA review panel - the closest regulatory comparables to K230459.
MF SC Facial Toning System
K233525 · Micro Current Technology, Inc. · Nov 2023
Nu Skin RenuSpa iO
K232001 · Nse Products, Inc. · Nov 2023
Beagank 4T Plus
K233010 · Belega, Inc. · Nov 2023
BTL-785BNF Handpiece
K232172 · BTL Industries, Inc. · Sep 2023
Medi Lift PLUS
K220198 · Ya-Man, Ltd. · Jun 2023
PureLift Pro Edition
K230506 · Xtreem Pulse · Jun 2023